ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

ClinicalTrials.gov ID: NCT04314544

Public ClinicalTrials.gov record NCT04314544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Study identification

NCT ID
NCT04314544
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sun Pharmaceutical Industries Limited
Industry
Enrollment
508 participants

Conditions and interventions

Interventions

  • TILD Drug
  • matching placebo injections Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2020
Primary completion
Mar 25, 2025
Completion
Dec 21, 2025
Last update posted
Jan 15, 2026

2020 – 2025

United States locations

U.S. sites
45
U.S. states
19
U.S. cities
44
Facility City State ZIP Site status
Sunpharma Site no 42 Dothan Alabama 36305
Sunpharma Site no 29 Gilbert Arizona 85297
Sunpharma Site no 30 Glendale Arizona 85306
Sunpharma Site no 31 Mesa Arizona 85210
Sunpharma Site no 35 Covina California 91722
Sunpharma Site no 48 Encino California 91436
Sunpharma site no. 17 Fountain Valley California 92708
Sunpharma site no. 15 Thousand Oaks California 91320
Sunpharma Site no. 141 Avon Park Florida 33825
Sunpharma site no. 21 Clearwater Florida 33765
Sunpharma site no. 02 Hialeah Florida 33016
Sunpharma Site no 55 Kissimmee Florida 34741
Sunpharma Site no. 75 Margate Florida 33063
Sunpharma site no. 05 New Port Richey Florida 34652
Sunpharma Site no. 76 Ocoee Florida 34761
SunPharma Site no 22 Tamarac Florida 33321
Sunpharma Site no 46 Gainesville Georgia 30501
Sunpharma Site no 41 Oak Brook Illinois 60523
Sunpharma Site no 54 Orland Park Illinois 60467
Sunpharma Site no 38 Schaumburg Illinois 60185
Sunpharma Site no 37 Skokie Illinois 60076
Sunpharma Site no. 122 Skokie Illinois 60077
Sunpharma site no. 20 Wichita Kansas 67207
Sunpharma site no. 07 Worcester Massachusetts 01605
Sunpharma site no. 14 Springfield Missouri 65810
Sunpharma Site no 53 Kalispell Montana 59901
Sunpharma Site no 27 Lincoln Nebraska 68516
Sunpharma Site no 44 Voorhees Township New Jersey 08043
Sunpharma Site no 52 Charlotte North Carolina 28204
Sunpharma Site no. 73 Leland North Carolina 28451
Sunpharma Site no 56 Wilmington North Carolina 28401
Sunpharma Site no 33 Minot North Dakota 58701
Sunpharma site no. 11 Middleburg Heights Ohio 44130
Sunpharma Site no. 124 Oklahoma City Oklahoma 73103
Sunpharma Site no 34 Greenville South Carolina 29601
Sunpharma Site no 50 Austin Texas 78745
Sunpharma site no. 13 Baytown Texas 77521
Sunpharma Site no 49 Colleyville Texas 76034
Sunpharma site no. 08 Houston Texas 77084
Sunpharma Site no 28 Lubbock Texas 79410
Sunpharma Site no. 74 Mesquite Texas 75150
Sunpharma site no. 16 San Antonio Texas 78229
Sunpharma Site no 26 Stafford Texas 77477
Sunpharma site no. 01 Tomball Texas 77375
Sunpharma Site no. 121 Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04314544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04314544 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →